1Acarturk E, Usal A, Demir M, et al. Thromboembolism risk in patients with mitral stenosis. Jpn Heart J, 1997,38 : 669--675.
2Li YH, Hwang JJ, Lin JL, et al. Importance of left appendage function as a risk factor for systemic thromboembolism in patients with rheumatic mitral valve disease. Am J Cardiol, 1996,78:844--847.
3Yamamoto K, Ikeda U, Seino Y, et al.Coagulation activity is increased in the left atrium of patients with mitral stenosis.J Am Coil Cardiol,1995,25 : 107--112.
4Fukuda Y, Nakamura K.The incidence of thromboembolism and the hemoagulative background in patients with rheumatic heart disease.Jpn Circ J, 1984,48 : 59--66.
5Easton JD, Sherman DG. Management of cerebral embolism of cardiac origin.Stroke, 1980,11:433--442.
6Maru M. Atrial fibrillation and embolic complications. East Air Med J,1997,74 : 3--5.
7Mahapatm RK, Agarwal JB, Chopra P. Systemic thromboembolism in rheumatic heart disease. Jpn Heart J, 1980,21:773--777.
8Karatasakis GT, Gotsis AC, Cokkinos DV. Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease. Am J Cardiol, 1995,76 :279--281.
9Kranidis A, Koulouris S, Filippatos G, et al. Mitml regurgitation protects from left atrial thrombogenesis in patients with mitral valve disease. Pacing Clin Electrophysiol, 2000,23( 11 Pt2) : 1863--1866.
10Petersen P,Godtfredsen J .Risk factors for stroke in chronic atrial fibrillation. Eur Heart J, 1988,9 : 291--294.
